Skip to main content
. 2022 Oct 13;13:1004044. doi: 10.3389/fendo.2022.1004044

Figure 1.

Figure 1

Overview of the biological glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) effects at the organ/tissue level (modified from (47)). The blue arrows depict relevant physiological effects.